MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Beyond the Periphery: Central Auditory Processing in Parkinsonian Disorders

    E. de Groote, K. de Keyser, A. Bockstael, D. Botteldooren, P. Santens, M. de Letter (Ghent, Belgium)

    Objective: This systematic review provides an overview of behavioral and event-related potential (ERP) studies investigating central auditory processing in patients with Parkinson’s disease (PD), progressive…
  • 2019 International Congress

    Plasma-based circulating long non-coding RNA AS-Uch1 as a novel diagnostic biomarker for Parkinson’s disease

    Y. Fan, Z. Xue (Wuhan, China)

    Objective: The study aimed to validate plasma-based circulating long non-coding RNA (lncRNA) as biomarker for the diagnosis of Parkinson's disease (PD). Background: Parkinson's disease (PD) is…
  • 2019 International Congress

    Synaptic dysfuncion in a Drosophila model of PARK14

    T. Hatano, A. Mori, T. Inoshita, K. Fukushima-Shiba, T. Koinuma, C. Yamashita, Y. Imai, N. Hattori (Tokyo, Japan)

    Objective: To investigate the association between lipid metabolism and synaptic function in Parkinson's disease (PD) due to PLA2G6 mutations. Background: The nervous system is enriched…
  • 2019 International Congress

    Assessment of occupationally exposed organic solvents and welding fumes induced DNA damage and SNPs (PARK13, LRRK2 and CAST gene) and risk of Parkinson’s disease

    K. Kalimuthu, R. Ramachndran, A. Arulsamy, S. Savariar (Annamalainagar, India)

    Objective: The aim of this study was to examine the potential association between solvents, welding fumes and SNPs and risk of developing PD. Background: The…
  • 2019 International Congress

    The impact of HIV on the severity and course of Parkinson’s disease: a clinical case

    A. Kudrevatykh, E. Gracheva, I. Miliukhina (St. Petersburg, Russian Federation)

    Objective: About 12 million people in the world suffer from Parkinson's disease (PD), and 36.9 million suffer from HIV. The proportion of people with HIV…
  • 2019 International Congress

    Fall History and Gait Variability can Predict Falls in Individuals With Parkinson’s Disease

    L. Ma, P. Chan (Beijing, China)

    Objective: To understand the risk factors for falls in PD patients; To explore clinical indicators and Mobility Lab parameters that can predict falls in patients…
  • 2019 International Congress

    High repressive activity of olive extracts on the cell line model of Parkinson disease against ROS induction

    D. Morshedi (Tehran, Islamic Republic of Iran)

    Objective: Neurodegenerative diseases including Parkinson’s disease (PD) mostly accompany with induction of high ROS in neuronal cells. It is believed that unusual level of ROS…
  • 2019 International Congress

    Safety and Tolerability of Apomorphine Sublingual Film During Maintenance Treatment in Patients With Parkinson’s Disease and “OFF” Episodes: A Pooled Analysis

    W. Ondo, A. Ellenbogen, S. Isaacson, A. Espay, C. Singer, P. Bhargava, M. Worden, D. Blum, B. Navia (Houston, TX, USA)

    Objective: To examine safety and tolerability of apomorphine sublingual film (APL-130277; APL) during maintenance treatment using pooled data from 4 clinical studies in patients with…
  • 2019 International Congress

    Association of Charcot-Marie-Tooth disease, Parkinson’s disease and FIG4 mutations

    I. Posada-Rodríguez, C. Domínguez-González (Madrid, Spain)

    Objective: Here we report a patient with Charcot-Marie-Tooth (CMT) 4J disease (related to FIG4 mutations) who developed an early-onset Parkinson’s disease during evolution. Background: FIG4 encodes…
  • 2019 International Congress

    Amylin and insulin in Parkinson’s disease patients: a clinical and metabolic study

    A. Sánchez-Gómez, M. Fernández, G. Alcarraz, R. Fernández, M. Ezquerra, A. Cámara, A. Novials, E. Muñoz, F. Valldeoriola, Y. Compta, MJ. Martí (Barcelona, Spain)

    Objective: To assess the possible connection between PD and glucose metabolism (GM) by analyzing the levels of biomarkers of GM in patients with PD. Background:…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley